News Bio-Techne Corporation

Stocks

TECH

US09073M1045

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-06-09 pm EDT			5-day change	1st Jan Change
54.41 ^USD	+3.34%		+9.32%	-7.48%

Jun. 04	Bio-Techne Corporation and Refeyn Announces Integrated Workflow for Bispecific Antibody and Biosimilar Characterization	CI
Jun. 04	Bio-Techne, Refeyn Introduce Antibody Testing Workflow	MT

All News

Mentions Relevance

Jun. 05	Bio-Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization	AQ
Jun. 04	Bio-Techne Corporation and Refeyn Announces Integrated Workflow for Bispecific Antibody and Biosimilar Characterization	CI
Jun. 04	Bio-Techne, Refeyn Introduce Antibody Testing Workflow	MT
Jun. 04	Bio‑Techne and Refeyn Close Critical Gap in Bispecific Antibody and Biosimilar Characterization	PR
May. 17		FA
May. 15	Bio-Techne's Planned Wilson Wolf Acquisition Underappreciated by Investors, RBC Says	MT
May. 12	Bio-Techne Insider Sold Shares Worth $320,386, According to a Recent SEC Filing	MT
May. 12	Bio-Techne Corporation Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 09:20 AM
May. 08	Stephens Adjusts Bio-Techne Price Target to $68 From $80	MT
May. 08	Deutsche Bank Adjusts Bio-Techne Price Target to $66 From $75, Maintains Buy Rating	MT
May. 06	Bio-Techne Corporation, Q3 2026 Earnings Call, May 06, 2026
May. 06	Bio-Techne Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026	CI
May. 06	Bio-Techne's Fiscal Q3 Adjusted Earnings, Revenue Fall	MT
May. 06	Bio-Techne misses revenue estimates as US academic funding cuts dent demand	RE
May. 06	Earnings Flash (TECH) Bio-Techne Corporation Reports Q3 Revenue $311.4M, vs. FactSet Est of $316.1M	MT
May. 06	Earnings Flash (TECH) Bio-Techne Corporation Posts Q3 Adjusted EPS $0.53 per Share, vs. FactSet Est of $0.53	MT
May. 06	Bio-Techne Declares Dividend	PR
May. 06	Bio-Techne Releases Third Quarter Fiscal 2026 Results	PR
May. 05	Bio-Techne Corporation announces Quarterly dividend, payable on May 29, 2026	CI
May. 04	Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare Conference	PR
Apr. 16	Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity	PR
Apr. 16	Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity	AQ
Apr. 16	Bio-Techne Corporation Introduces Streamlined Brand Architecture With Three Portfolio Brands	CI
Apr. 14	Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results	PR
Apr. 13	TD Cowen Adjusts Price Target on Bio-Techne to $65 From $80, Maintains Buy Rating	MT